Authors:
de Boer, R
Hillen, HFP
Roumen, RMH
Rutten, HJT
van der Sangen, MJC
Voogd, AC
Citation: R. De Boer et al., Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer, BR J SURG, 88(1), 2001, pp. 118-122
Authors:
Nijziel, MR
van Oerle, R
van Pampus, ECM
de Vet, HCW
Hillen, HFP
Hamulyak, K
Citation: Mr. Nijziel et al., Increased D-dimer levels correlate with binding of activated protein C, but not tissue factor expression, on peripheral blood monocytes in cancer patients, AM J HEMAT, 64(4), 2000, pp. 282-286
Citation: Aw. Saleh et al., Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy, ACT HAEMAT, 102(1), 1999, pp. 31-37
Authors:
Huinink, WWT
de Swart, CAM
van Toorn, DW
Morack, G
Breed, WPM
Hillen, HFP
van der Hoeven, JJM
Reed, NS
Fairlamb, DJ
Chan, SYT
Godfrey, KA
Kristensen, GB
van Tinteren, H
Ehmer, B
Citation: Wwt. Huinink et al., Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients withovarian carcinoma treated with platinum-based chemotherapy, MED ONCOL, 15(3), 1998, pp. 174-182
Authors:
Jansen, RLH
Joosten-Achjanie, SR
Volovics, A
Arends, JW
Hupperets, PSGJ
Hillen, HFP
Schouten, HC
Citation: Rlh. Jansen et al., Relevance of the expression of Bcl-2 in combination with p53 as a prognostic factor in breast cancer, ANTICANC R, 18(6A), 1998, pp. 4455-4462